Cargando…

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines

Vaccination remains the most effective and essential prophylactic tool against infectious diseases. Enormous efforts have been made to develop effective vaccines against malaria but successes remain so far limited. Novel adjuvants may offer a significant advantage in the development of malaria vacci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabral-Miranda, Gustavo, M. Salman, Ahmed, O. Mohsen, Mona, L. Storni, Federico, S. Roesti, Elisa, A. Skinner, Murray, D. Heath, Matthew, F. Kramer, Matthias, M. Khan, Shahid, J. Janse, Chris, V. S. Hill, Adrian, F. Bachmann, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313579/ https://www.ncbi.nlm.nih.gov/pubmed/30469323 http://dx.doi.org/10.3390/diseases6040107

Ejemplares similares

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2017)

Microcrystalline Tyrosine (MCT(®)): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2017)

Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2019)

Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2020)

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
por: Klimek, Ludger, et al.
Publicado: (2018)

Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus
por: Roesti, Elisa S., et al.
Publicado: (2020)

Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT(®))
por: Heath, Matthew D., et al.
Publicado: (2020)

Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine
por: Hankaniemi, Minna M., et al.
Publicado: (2020)

Direct fluorescent labelling of clones by DOP PCR
por: Backx, Liesbeth, et al.
Publicado: (2008)

VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
por: Prates-Syed, Wasim A., et al.
Publicado: (2021)

The educational impact of assessment: A comparison of DOPS and MCQs
por: Cobb, Kate A., et al.
Publicado: (2013)

CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2–DOP receptor heterodimer
por: Parenty, Geraldine, et al.
Publicado: (2008)

Improved DOP-PCR (iDOP-PCR): A robust and simple WGA method for efficient amplification of low copy number genomic DNA
por: Blagodatskikh, Konstantin A., et al.
Publicado: (2017)

In situ delivery of nanoparticles formulated with micron-sized crystals protects from murine melanoma
por: Mohsen, Mona O, et al.
Publicado: (2022)

Intranasal administration of a VLP‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern
por: Rothen, Dominik A., et al.
Publicado: (2022)

Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2021)

SapC-DOPS – a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy
por: N’Guessan, Kombo F., et al.
Publicado: (2020)

Anti-IgE Qb-VLP Conjugate Vaccine Self-Adjuvants through Activation of TLR7
por: Akache, Bassel, et al.
Publicado: (2016)

Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer
por: Chu, Zhengtao, et al.
Publicado: (2013)

Detection of cancer cells using SapC-DOPS nanovesicles
por: Davis, Harold W., et al.
Publicado: (2016)

“The Dop System of Alcohol Distribution is Dead, but It’s Legacy Lives On….”
por: May, Philip A., et al.
Publicado: (2019)

Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement
por: Schmidt, Frederik L., et al.
Publicado: (2021)

Potentiating the Immune Responses of HBsAg-VLP Vaccine Using a Polyphosphoester-Based Cationic Polymer Adjuvant
por: Liu, Xuhan, et al.
Publicado: (2023)

On the Effect of Thermodynamic Equilibrium on the Assembly Efficiency of Complex Multi-Layered Virus-Like Particles (VLP): the Case of Rotavirus VLP
por: Roldão, António, et al.
Publicado: (2012)

VLP‐factory™ and ADDomer(©): Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display
por: Sari‐Ak, Duygu, et al.
Publicado: (2021)

Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice
por: Lee, Katherine S, et al.
Publicado: (2023)

Correction: Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer
Publicado: (2015)

Molybdenum Dopped Copper Ferrites as Active Catalysts for Alcohols Oxidative Coupling
por: Mitran, Gheorghiţa, et al.
Publicado: (2019)

Validation of the Donkey Pain Scale (DOPS) for Assessing Postoperative Pain in Donkeys
por: de Oliveira, Maria Gláucia Carlos, et al.
Publicado: (2021)

RNA Phage VLP-Based Vaccine Platforms
por: Peabody, David S., et al.
Publicado: (2021)

Erythro-VLP: Erythrocyte Virus-Like-Particles
por: Himbert, Sebastian, et al.
Publicado: (2021)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge
por: Wong, Ting Y., et al.
Publicado: (2022)

SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma
por: Wojton, Jeffrey, et al.
Publicado: (2014)

Direct observation of procedural skills (DOPS) evaluation method: Systematic review of evidence
por: Erfani Khanghahi, Masoumeh, et al.
Publicado: (2018)

DOP Stimulates Heterotrophic Bacterial Production in the Oligotrophic Southeastern Mediterranean Coastal Waters
por: Sisma-Ventura, Guy, et al.
Publicado: (2019)

Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles
por: Davis, Harold W., et al.
Publicado: (2019)

Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles
por: Davis, Harold W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pa1ilfhb3ndfj0i30l5cgafn8k